Imunexus Therapeutics Limited
Biotechnology Research • 
Melbourne, Victoria, Australia • 1-10 Employees
Company overview
| Headquarters | Science Dr, LIMS2 Building, Bundoora, Victoria 3086, AU |
| Website | |
| SIC | 873 |
| Employees | 1-10 |
Key Contact at Imunexus Therapeutics Limited
Don Brumley
Non Executive Director
Imunexus Therapeutics Limited Email Formats
Imunexus Therapeutics Limited uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@imunexus.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@imunexus.com | 66.7% |
{first initial}.{last name} | j.doe@imunexus.com | 33.3% |
About Imunexus Therapeutics Limited
Imunexus' technology facilitates rapid, cost-effective, lower risk, generation of effective therapeutics by converting existing monoclonal antibodies into multispecifics with additional therapeutic utility. Our technology will generate a number of potential products for the treatment of a number of cancers, autoimmune and other serious diseases.
Imunexus Therapeutics Limited revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Imunexus Therapeutics Limited has never raised funding before.
Imunexus Therapeutics Limited Tech Stack
Discover the technologies and tools that power Imunexus Therapeutics Limited's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Maps
UI frameworks
CDN
JavaScript libraries
Security
Analytics
Web frameworks
PaaS
Tag managers
United States
United Kingdom
CanadaFrequently asked questions
4.8
40,000 users
